AnaptysBio announced that its CEO, Daniel Faga, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on May 6, 2026. The company focuses on managing financial collaborations for its drugs Jemperli with GSK and imsidolimab with Vanda, aiming to protect and return royalty value to shareholders. This event provides an opportunity for investors to hear directly from the CEO about the company's strategies and outlook. The fireside chat is scheduled for 1:30pm ET and interested parties can register online.
Warner Bros. Discovery's stock fell 4% following a court decision to pause the $110 billion merger deal between Paramount and Skydance. The judge's intervention raises uncertainty about the future of this major entertainment industry consolidation. I...
Bitcoin's mining difficulty fell by 0.74% at block 959616, marking the 15th adjustment in 2026 with more cuts than increases. The difficulty drop reflects a 13.82% decline since January, driven mainly by a 26% fall in Bitcoin's price and miners reall...
The XRP community has clarified that Ripple currently holds 32.445 billion XRP in escrow, addressing confusion from outdated figures circulating on social media. This number is verified by the XRP Ledger explorer XRPScan and confirmed by the XRP Ledg...
Flare Networks CEO Hugo Philion announced a six-month plan to transform the XRP decentralized finance ecosystem, XRPFi, by enabling smart contract functionality on the XRP Ledger through Flare's programmable layer. This will allow XRP holders to use ...
Lido corrected a reporting error in its stETH staking yield caused by a missed 32 ETH validator deposit. This omission briefly lowered the reported annual percentage rate (APR) from about 2.15% to 2.04%, but was quickly fixed with a rebase that adjus...
